Sort   by:  
 Page size 
UnknownOutpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events.
Not available
S-EPMC9875606 | biostudies-literature
UnknownThe anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial.
Not available
S-EPMC11828896 | biostudies-literature
UnknownCN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models.
Not available
S-EPMC7409080 | biostudies-literature
UnknownIntegrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.
Not available
S-EPMC10164134 | biostudies-literature
UnknownNoninvasive Ventilation for Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study.
Not available
S-EPMC10524424 | biostudies-literature
UnknownThe gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Not available
S-EPMC9679167 | biostudies-literature
UnknownChildhood Sjogren syndrome: features of an international cohort and application of the 2016 ACR/EULAR classification criteria.
Not available
S-EPMC8487648 | biostudies-literature
UnknownWorldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.
Not available
S-EPMC12401577 | biostudies-literature
UnknownBronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
Not available
S-EPMC9741866 | biostudies-literature
UnknownHLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.
Not available
S-EPMC4702958 | biostudies-literature
Sort   by:  
 Page size